Pharmaguy's Insights Into Drug Industry News
186.1K views | +13 today
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy!

Trump Is Turning U.S. Health Agencies Into a “Pharma Swamp”

Trump Is Turning U.S. Health Agencies Into a “Pharma Swamp” | Pharmaguy's Insights Into Drug Industry News |

President Trump has vilified the pharmaceutical industry and made bold promises to lower prescription drug prices. But when it comes to staffing the health care agencies empowered to oversee those efforts, he has turned regularly to the pharmaceutical industry.


His Food and Drug Administration chief, Scott Gottlieb, was a longtime industry investor and adviser to major players like GlaxoSmithKline and Bristol-Myers Squibb. A senior adviser at the Health and Human Services Department, Keagan Lenihan, joined the administration after running the lobby shop for the drug and distribution giant McKesson. Tim Clark, the White House liaison for political personnel at HHS, was still lobbying for pharma company Eisai earlier this year. And Trump has a former Gilead lobbyist, Joe Grogan, reviewing health care regulations at the Office of Management and Budget. The chief of staff at HHS, Lance Leggitt, lobbied for a whole host of drug clients, even last year.


This week the president named Alex Azar, who spent more than a decade at the pharmaceutical giant Eli Lilly, as his health secretary nominee.


It’s a lengthy list that highlights just how reliant Trump is on the industry he has promised time and again to rein in. And his picks stand out when compared with those of previous administrations. In a STAT review of the public biographies of more than five dozen top health officials and advisers across the Obama, Bush and Clinton administrations, only a handful of individuals appear to have joined the administration directly from the private sector.


“The trends in pharmaceuticals kind of run in parallel to the trends in the financial sector and Wall Street — you have an industry that Trump ran against pretty aggressively, with pretty strident language in 2016, and he is now seeing those industries as essentially farm clubs. He’s going to bring them up to the major leagues of his administration,” said Jeff Hauser, who runs the Revolving Door Project at the Center for Economic and Policy Research. “It’s unusually stark and unapologetic.”


Further Reading:

K.I.R.M. God is Business " From Day One"'s curator insight, December 12, 2017 3:46 AM

An creative way to eliminate the poor, sick and health care needy using the government to get it done. If the assistance with health care cost including but not limited to medication and supplement life support and like manner of things needed to stay alive then it is true that those people that need them but can not afford to pay the cost of their medical needs will eventually die and by doing so in like manner and for like reasons the government are murderers using an creative method of elimination that when done by others they are punished by the same governmental system of doing things. Now this is the land of remove the oxygen and let them die, no more medication let them die, no more health care assistance for the poor, middle class and the in need let them die, the land of taking care of everyone else's but its own, the land of racisn,classism made legal. What has really happened? Nothing really its just that what use to be classified done behind closed doors has been made open to the public in a way that say's can you hear me now and dead sick people can't respond, they should have heard that one coming. Some did and did nothing to stop it but make it appear they did something. Sad world but real world we live in.

Scooped by Pharma Guy!

If Alex Azar Is Confirmed as HHS Secretary, the Big Pharma/Gov’t Swamp Will Get Worse

If Alex Azar Is Confirmed as HHS Secretary, the Big Pharma/Gov’t Swamp Will Get Worse | Pharmaguy's Insights Into Drug Industry News |

If Alex Azar Is Confirmed as HHS Secretary, Big Pharma’s Coup of Health Care Sphere Will Be Virtually Complete

Statement of Robert Weissman, President, Public Citizen

Note: Media reports indicate that President Donald Trump is likely to nominate Alex Azar, who served for five years as president of Lilly USA, LLC, the largest affiliate of global biopharmaceutical leader Eli Lilly and Company, to be the next U.S. Secretary of Health and Human Services.

Just days after denouncing “out-of-control” drug prices, President Donald Trump appears set to show he doesn’t mean it by naming a former pharmaceutical company executive to run the U.S. Department of Health and Human Services. If Alex Azar is nominated and his nomination confirmed, then Big Pharma’s coup d’etat in the health care sphere will be virtually complete.

In his public statements, Alex Azar has made clear that he is opposed to measures to restrain drug company profiteering and limit improper marketing and favors weaker drug safety approval standards.

Americans understand, passionately, that drug company price gouging leads to rationing of care. It is unethical and must end. Even President Trump says so. But it is highly unlikely that a pharmaceutical company executive who has made passionate arguments against price restraints is going to advance real reform. Much more likely is that he serves as the instrument by which Big Pharma aims to defend its monopolies and unaffordable prices.

The swamp only gets worse. Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman, and let a pharmaceutical executive literally run the health department.

K.I.R.M. God is Business " From Day One"'s curator insight, December 12, 2017 4:05 AM

How will the Health Care cuts effect the world of pharmacy drugs? Will the Drug Dealers become the new day pharmacist using their connections to keep the sick, poor and needy for medication to stay alive but without insurance assistance they can't afford. Yes they are smart beyond what some may look and think but consider who they are getting theirs from. Its going to be a new day in the drug industry because people are not going to see their own die when they can help their people out in a its about staying alive thing made personal, NOW! Will the Dug Dealers become new day Pharmacist that help keep their people alive by providing medications needed to stay alive because of health care assistance terminated therefore so is lives?